Universitätsklinikum Schleswig-Holstein (UKSH)

Predictive role of HER2/neu, topoisomerase-II-alpha, and tissue inhibitor of metalloproteinases (TIMP-1) for response to adjuvant taxane-based chemotherapy in patients with intermediate-risk breast cancer: results from the WSG-AGO EC-Doc trial (2015) Erber R, Gluz O, Brünner N, Kreipe HH, Pelz E, Kates R, Bartels A, et al. Journal article A self-enforcing CD44s/ZEB1 feedback loop maintains EMT and stemness properties in cancer cells (2015) Preca BT, Bajdak K, Mock K, Sundararajan V, Pfannstiel J, Maurer J, Wellner U, et al. Journal article Integrated prostate cancer centers might cause an overutilization of radiotherapy for low-risk prostate cancer: A comparison of treatment trends in the United States and Germany from 2004 to 2011 (2015) Hager B, Kraywinkel K, Keck B, Katalinic A, Meyer M, Zeissig SR, Stabenow R, et al. Journal article Long-Term Outcomes After Treatment With a Paclitaxel-Coated Balloon Versus Balloon Angioplasty: Insights From the PEPCAD-DES Study (Treatment of Drug-eluting Stent [DES] In-Stent Restenosis With SeQuent Please Paclitaxel-Coated Percutaneous Transluminal C (2015) Rittger H, Waliszewski M, Brachmann J, Hohenforst-Schmidt W, Ohlow M, Brugger A, Thiele H, et al. Journal article Expression of secreted protein acidic and rich in cysteine (SPARC) in breast cancer and response to neoadjuvant chemotherapy (2015) Lindner JL, Loibl S, Denkert C, Ataseven B, Fasching P, Pfitzner BM, Gerber B, et al. Journal article Genetic variants in VEGF pathway genes in neoadjuvant breast cancer patients receiving bevacizumab: Results from the randomized phase III GeparQuinto study (2015) Hein A, Lambrechts D, Von Minckwitz G, Haeberle L, Eidtmann H, Tesch H, Untch M, et al. Journal article Immunohistological expression of human ß-defensin-1 and human ß-defensin-2 in exacerbation of acute and secondary chronic osteomyelitis of the mandible (2015) Beck-Broichsitter BE, Dau H, Moest T, Jochens A, Stockmann P, Wiltfang J, Becker ST Journal article Omission of dacarbazine or bleomycin, or both, from the ABVD regimen in treatment of early-stage favourable Hodgkin's lymphoma (GHSG HD13): an open-label, randomised, non-inferiority trial (2015) Behringer K, Goergen H, Hitz F, Zijlstra JM, Greil R, Markova J, Sasse S, et al. Journal article Assessing family medicine trainees - what can we learn from the European neighbours? (2015) Flum E, Maciek RM, Cwirko G, Scarborough N, Scherpbier N, Ledig T, Roos M, et al. Journal article S2k guidelines for the treatment of pemphigus vulgaris/foliaceus and bullous pemphigoid (2015) Eming R, Sticherling M, Hofmann SC, Hunzelmann N, Kern JS, Kramer H, Pfeiffer C, et al. Journal article